The expression of GATA3, a transcription factor responsible for promotion of the differentiation of Th2 cells and the inhibition of Th1 development [38], was found to be increased in the benign tumors in comparison to healthy tissue as well as malignant and metastatic neoplasms (Figure 4B). This evidence concerns the gene GATA3 and metastatic neoplasm.